ODTX — ODYSSEY THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 63 SEC-registered investment managers reported holding ODTX (ODYSSEY THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $659.12M across 35.70M shares. Ownership is concentrated: the five largest holders account for 54.7% of reported value and the top ten for 70.5%.
Compared with the prior quarter, 63 opened new positions. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ODYSSEY THERAPEUTICS INC (ODTX) include Fidelity Management & Research (FMR), Lightspeed Management Company, L.L.C., SR ONE CAPITAL MANAGEMENT, LP, ranked by reported 13F value among the 79 institutional holders on this page.
ODTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding ODTX
The superinvestors we track who report ODTX in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q2 2026 | 831.66K | $15.56M | 1.87% | New |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 41 | 18.56M | $408.85M | +15.4% |
| Q2 2026 | 63 | 35.70M | $659.12M | — |
Over the 2 quarters shown, institutional share counts decreased 48% in aggregate (Q2 2026 → Q3 2026).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 6.24M | $135.84M | 0.01% | Add | |
| 3.61M | $80.18M | 3.95% | Hold | |
| 1.99M | $44.22M | 7.02% | Hold | |
| 1.26M | $28.00M | 1.30% | Add | |
| 1.14M | $25.42M | 0.00% | Add | |
| 875.00K | $19.44M | 2.88% | Hold | |
| 734.31K | $16.32M | 0.00% | Add | |
| 575.00K | $12.78M | 1.45% | Hold | |
| 425.37K | $9.45M | 0.00% | Add | |
| 309.29K | $6.87M | 0.00% | New | |
| 297.04K | $6.60M | 0.01% | Reduce | |
| 275.02K | $5.36M | 0.00% | Hold | |
| 200.00K | $4.44M | 0.11% | Hold | |
| 114.88K | $2.55M | 0.00% | Add | |
| 109.01K | $2.42M | 0.00% | Add | |
| 79.94K | $1.78M | 0.00% | Reduce | |
| 48.24K | $1.07M | 0.00% | Reduce | |
| 37.55K | $834.25K | 0.00% | New | |
| 37.24K | $827.50K | 0.00% | Add | |
| 30.00K | $666.60K | 0.01% | Reduce | |
| 29.13K | $653.77K | 0.00% | Hold | |
| 22.97K | $510.46K | 0.00% | New | |
| 16.03K | $356.28K | 0.00% | Add | |
| 15.11K | $335.72K | 0.00% | New | |
| 14.11K | $313.44K | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
New Positions (Q2 2026)
- Fidelity Management & Research (FMR) 5.18M sh · $96.90M
- SR ONE CAPITAL MANAGEMENT, LP 3.79M sh · $71.00M
- TPG GP A, LLC 3.69M sh · $69.04M
- Lightspeed Management Company, L.L.C. 3.61M sh · $67.51M
- ORBIMED ADVISORS LLC 3.00M sh · $56.15M
- Sanofi 1.99M sh · $37.27M
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.05M sh · $19.57M
- Sands Capital Alternatives, LLC 875.00K sh · $16.37M
- Hillhouse Capital (HHLR Advisors) 831.66K sh · $15.56M
- General Catalyst Group Management, LLC 810.27K sh · $15.16M
- Affinity Asset Advisors, LLC 766.35K sh · $14.34M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 725.00K sh · $13.56M
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 |
|---|---|---|
| Fidelity Management & Research (FMR) | 6.24M | 5.18M |
| Lightspeed Management Company, L.L.C. | 3.61M | 3.61M |
| Sanofi | 1.99M | 1.99M |
| Affinity Asset Advisors, LLC | 1.26M | 766.35K |
| BlackRock Inc | 1.14M | 240.68K |
| Sands Capital Alternatives, LLC | 875.00K | 875.00K |
| VANGUARD CAPITAL MANAGEMENT LLC | 734.31K | 720.44K |
| Vivo Capital, LLC | 575.00K | 575.00K |
| Geode Capital Management | 425.37K | 189.49K |
| STATE STREET CORP | 309.29K | — |
| Marshall Wace | 297.04K | 492.70K |
| Franklin Resources | 275.02K | 275.02K |
| Siren, L.L.C. | 200.00K | 200.00K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 114.88K | 13.69K |
| VANGUARD FIDUCIARY TRUST CO | 109.01K | 100.91K |
| Aberdeen Group plc | 79.94K | 165.00K |
| Ensign Peak Advisors, Inc | 48.24K | 64.62K |
| BNY Mellon | 37.55K | — |
| Manulife Financial | 37.24K | 32.12K |
| Hudson Bay Capital Management LP | 30.00K | 72.92K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ODTX?
As of 2026-Q2, 63 institutional funds reported holding ODTX (ODYSSEY THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $659.12M.
How many shares of ODTX do institutions own?
13F filers reported 35.70M shares of ODTX, worth $659.12M in aggregate at the end of 2026-Q2.
Is institutional ownership of ODTX rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of ODTX?
The largest 13F holders are Fidelity Management & Research (FMR), Lightspeed Management Company, L.L.C., SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, ORBIMED ADVISORS LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ODYSSEY THERAPEUTICS INC?
The major shareholders of ODYSSEY THERAPEUTICS INC (ODTX) by reported 13F value are Fidelity Management & Research (FMR), Lightspeed Management Company, L.L.C., SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, ORBIMED ADVISORS LLC, among 79 institutional holders.
Which legendary investors own ODTX?
1 of the legendary investors tracked on HoldingsHub report ODTX (ODYSSEY THERAPEUTICS INC) in their latest 13F filings, led by Lei Zhang. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ODTX?
1 tracked superinvestors hold ODTX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.